UK Watchdog Says UnitedHealth Takeover Of EMIS Could Hurt National Health Service
The UK competition regulator released a statement on Friday that the initial investigation into UnitedHealth’s 1.24 billion-pound acquisition of EMIS could reduce competition, leading to potentially negative outcomes for National Health Service, patients, and taxpayers.
The Competition and Markets Authority said the deal to combine the healthcare software and data specialists could lead to lower quality and more expensive software options for the NHS.
Related: DOJ To Appeal Loss In UnitedHealth-Change Merger Challenge
In particular, competition could be substantially reduced in the so-called population health management and medicines-optimization software markets, which enable the safe and effective use of medicines, the CMA said.
The takeover offer was first disclosed in June 2022, and was made by Bordeaux an affiliate of Optum Health Solutions, and subsidiary of UnitedHealth.
The CMA is concerned the deal could affect services provided by Optum’s competitors, as they rely on digital connections to the data EMIS holds, and integrations with EMIS’s electronic patient record system.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition – Year of the Dragon
Apr 16, 2024 by
CPI
Review Logic and Rules for Concentrations of Undertakings that Do Not Meet the Standard of Notification
Apr 16, 2024 by
CPI
China’s Review of Semiconductor Transactions
Apr 16, 2024 by
CPI
Key Challenges and Tips for Merger Control Filing in China for Listed Companies
Apr 16, 2024 by
CPI
Key Point Review: China SPC Antitrust Judgments in 2023
Apr 16, 2024 by
CPI